Name: Receivables Turnover

Definition: Receivables turnover tells you how quickly the company collects payments from customers after making sales on credit. A high turnover means customers pay on time and cash flows smoothly. Slow turnover suggests delayed collections, which can create cash shortages and financing stress.

Interpretation:
• In '2021', NRC's receivables turnover was 10.22, showing efficiency in collecting outstanding receivables. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2021' stood at 3.19.
• In '2022', NRC's receivables turnover was 10.22, showing efficiency in collecting outstanding receivables. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2022' stood at 3.95. Industry average increased by 0.76 compared to previous year.
• In '2023', NRC's receivables turnover was 10.71, showing efficiency in collecting outstanding receivables. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2023' stood at 4.44. Industry average increased by 0.48 compared to previous year.
• In '2024', NRC's receivables turnover was 12.06, showing efficiency in collecting outstanding receivables. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2024' stood at 5.65. Industry average increased by 1.21 compared to previous year.
Overall, NRC's receivables turnover has steadily improved over the past 4 years.

Formula: Receivables Turnover = Net Credit Sales / Average Accounts Receivable

Good Range: Ranges 5 to 15 depending on credit terms.